Navigation Links
OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
Date:3/17/2010

ROCKVILLE, Md., March 17 /PRNewswire/ --  OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round.  The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.  

"We are delighted by this vote of confidence from our existing and new investors and share their enthusiasm for our growth strategy and execution.  The funding will propel us closer to meeting our goal of building the largest monoclonal antibody collection in the world covering the entire human genome of approximately 20,000 genes," said Wei-Wu He, OriGene's Chairman and Chief Executive Officer.

The TrueMAB™ Collection of monoclonal antibodies will be developed with the most up-to-date antibody technologies and will be significantly different from many antibodies on the market, as OriGene will be using authentic human full-length proteins as immunogens during the manufacturing process. OriGene has dedicated the last decade to build the largest collection of human full-length cDNA clones in the world. The collection has enabled OriGene to manufacture human full-length proteins directly from human cells for producing monoclonal antibodies. TrueMAB™ monoclonal antibodies generated by authentic human antigen, have been proven far superior in quality than traditional small peptide generated monoclonal and polyclonal antibodies, especially in applications such as flow cytomery and multiplex ELISA assays. Many of these monoclonal antibodies are currently available and will be utilized by multiple commercial partners for various applications.

About OriGene Technologies

OriGene Technologies, Inc., is a gene centric life sciences tool company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery.  OriGene's novel product line includes the world's largest cDNA and shRNA clone collections, over 5,000 purified human proteins, high quality monoclonal antibodies (TrueMAB), 100,000 highly validated human tissues, and Luminex Multiplex Assay Products.  OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is committed to its mission to be "Your Gene Company;" in supplying everything a researcher would need for gene based research. For more information, visit www.origene.com.

SOURCE OriGene Technologies, Inc.

Back to top

RELATED LINKS
http://www.origene.com

'/>"/>

SOURCE OriGene Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OriGene Technologies Acquires Marligen Biosciences
2. OriGene Launches 5,000 Purified Human Proteins from HEK293 Cells
3. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
4. OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector
5. DHS Technologies Launches VTAP 2.0
6. DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger
7. OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
8. Netsmart Technologies Selected by Douglas Gardens Community Mental Health to Provide Behavioral Health Software Solution
9. China Medical Technologies Reports Third Fiscal Quarter Financial Results
10. Doctors and First Responders Rely on Oberthur Technologies in Times of Emergency
11. Fortrex Technologies Achieves HITRUST Common Security Framework Assessor Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):